Katwal Srijana, Malbul Kiran, Mandal Sujit Kumar, Kc Soniya, Alam Md Zafar, Karki Parag, Pant Chiranjibi
Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
Department of Medicine, Resident of Internal Medicine, Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
Ann Med Surg (Lond). 2021 Sep 17;70:102868. doi: 10.1016/j.amsu.2021.102868. eCollection 2021 Oct.
and Importance: Aluminum phosphide (ALP) is a commonly available pesticide in agricultural countries like Nepal. Upon ingestion, this releases highly toxic phosphine gas in the gastrointestinal tract when it comes in contact with humidity. This leads to refractory shock, metabolic acidosis, cardiac arrhythmia, renal failure, and hepato-biliary impairment.
We present a successfully managed case of a 17-year-old girl who ingested 6 g (2 tablets) of ALP tablets with suicidal intent. Although the mortality has been reported as 70-100% with mere ingestion of 150-500 mg of ALP, this case survived even after developing severe metabolic acidosis, acute renal failure, refractory shock, and ventricular tachycardia.
ALP poisoning is most often lethal. However, there is an emerging evidence of successful use of various drugs such as magnesium sulfate, trimetazidine, and other interventions such as intra-aortic balloon pump and extra corporeal membrane oxygenation in case of ALP poisoning.
Owing to the unavailability of an effective antidote of ALP to date, we emphasize early initiation of supportive management, intensive monitoring, and potential role of membrane stabilizers like magnesium sulfate, and cardio-protective agents like trimetazidine, -Acetyl cysteine, thiamine, vitamin C, and hydrocortisone in decreasing the likelihood of fatal outcome.
及其重要性:磷化铝(ALP)在尼泊尔等农业国家是一种常见的农药。摄入后,它在胃肠道中与湿度接触时会释放出剧毒的磷化氢气体。这会导致难治性休克、代谢性酸中毒、心律失常、肾衰竭和肝胆损害。
我们报告一例成功救治的17岁女孩,她出于自杀意图摄入了6克(2片)磷化铝片剂。尽管据报道仅摄入150 - 500毫克磷化铝的死亡率为70 - 100%,但该病例即使在出现严重代谢性酸中毒、急性肾衰竭、难治性休克和室性心动过速后仍存活。
磷化铝中毒通常是致命的。然而,有新证据表明在磷化铝中毒时成功使用了各种药物,如硫酸镁、曲美他嗪,以及其他干预措施,如主动脉内球囊泵和体外膜肺氧合。
由于迄今为止尚无有效的磷化铝解毒剂,我们强调早期启动支持性治疗、加强监测,以及硫酸镁等膜稳定剂和曲美他嗪、乙酰半胱氨酸、硫胺素、维生素C和氢化可的松等心脏保护剂在降低致命结局可能性方面的潜在作用。